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Abstract 
Aim: To elucidate the protective effects of Matrine on atrial fibrillation (AF) induced by electric 
pacing in mice and underlying molecular and ion channel mechanisms.  
Methods: AF was introduced by electric pacing in mice and the incidence and duration of AF 
were evaluated. Functional expression of M3 receptor (M3-R) and Cav1.2 were explored by 
western and Real-time PCR, action potential (AP) and the density of (IKM3) L-type calcium 
channel (ICa-L) were both recorded using whole-cell patch in isolated atrial cardiomyocytes. 
Results: In control group, incidence and duration of AF induced by electric pacing were 50 ± 
17% and 3.68 ± 1.84 s, respectively; after application of carbachol 50 µg/kg both incidence and 
duration of AF were significantly increased to 86 ± 24% and 65.2 ± 29.0 s. Compared with 
control group, pretreatment of Matrine for 15 days significantly reduced AF incidence and 
duration in dose-dependent manner. Atrial membrane-protein expression of M3-R was de-
creased and membrane Cav1.2 expression was up-regulated. In single Matrine-treated atrial 
cardiomyocyte the density of IKM3 was significantly decreased by 39% as well compared with 
control group, P < 0.05, whereas, ICa-L density of atrium was increased by 40%.  
Conclusion: These data demonstrated at the first time that the anti-AF effects of Matrine may 
due, at least in part, to down-regulation of IKM3 density and M3-R expression and up-regulation 
of ICa-L density and α1C/Cav1.2 expression. 
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Introduction 
Atrial  fibrillation  (AF)  is  the  most  common 
tachyarrhythmia in clinics and its incidence increases 
with age by nearly 10% of people at age over 80 [1,2]. 
AF leads to severe cardiovascular morbidity and dis-
ability [3,4]. Current drug therapy for AF is somehow 
unsatisfied, so, a better understanding of arrhythmic 
mechanisms may allow for safer and more effective 
clinical management in patients with AF [5,6]. 
Both parasympathetic tone and electric remod-
eling of atrial ion channel play an important role in 
the pathophysiology of AF [7,8]. Studies from Yang’s 
group  and  Wang’s  laboratory  [9-11]  demonstrated 
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that  several  non-selective  Muscarinic  acetylcholine 
receptor  (AchR)  agonists  including  choline  (0.1–10 
mM),  pilocarpine  (0.1–10  µM),  and  tetrame-
thylammonium (TMA) (1–10 mM) each can induce a 
similar novel delayed rectiﬁer K+ current (termed as 
IKM3, meaning the M3-receptor-activated delayed rec-
tiﬁer  K+ current)  in  dispersed  cardiomyocytes  from 
guinea-pig and canine atria. IKM3 could accelerate car-
diac  repolarization  and  shorten  the  effective  refrac-
tory period (ERP), an effect favoring the occurrence of 
reentrant  arrhythmias.  It  is  well-known  that 
M2-receptor (M2-R) and coupled K+ channel subunits 
are major parasympathetic constitution. In the atrium 
of dogs with AF induced by CHF the densities of the 
M3-R and IKM3 current are both robustly increased, but 
those of the M2-R are abrogated [12]. G-protein sig-
naling proteins 2 (RGS) regulate atrial M3-R signaling 
and block the M3R signal transduction. The RGS2-/- 
mice have enhanced susceptibility to AF via enhanc-
ing M3-R activity [13]. These results indicate that the 
M3-R  may  play  an  important  role  in  pathological 
condition and contribute to initiation and perpetua-
tion of AF. 
Abnormalities in intracellular Ca2+ handling may 
constitute key missing links in AF-initiating focal ac-
tivity and AF perpetuation by rapidly ﬁring foci and 
reentry [14,15]. In patients with AF, increased atrial 
rates  enhance  cardiomyocyte  Ca2+  inﬂux  with  each 
action potential (AP). To prevent potentially cytotoxic 
Ca2+ overload, atrial cardiomyocytes limit Ca2+ inﬂux 
through  accelerating  ICa-L  inactivation  and 
down-regulation  of  mRNA  encoding  ICa-L,  conse-
quently resulting in decrease in both ICa-L and atrial 
AP duration (APD), which, in turn, relatively increase 
in ERP [16,17]. In clinical therapy of AF, current Ca2+ 
channel blockers are frequently used to reduce Ca2+ 
overload  with  the  expectation  that  prevents  ar-
rhythmogenic  remodeling,  however,  it  actually  ag-
gregates down-regulation of ICa-L in the atrium so as to 
increase the risk of ventricular arrhythmia and does 
not show a beneficial effects on AF [18,19]. The elec-
trical  remodeling  paradigm  and  unsatisfied  thera-
peutic effects of current Ca2+ channel blockers in AF 
treatment lead us to find new efficient compound that 
can  be  used  in  AF  clinical  management  without 
down-regulating Ca2+ channel. 
Sophora flavescens Ait (SF), used as the dry root, 
is a traditional herb medicine found in China, Japan, 
and some European countries and has long been used 
as an anti-inflammatory and anti-cancer agents [20]. 
Among  various  alkaloids  isolated  from  SF,  Matrine 
(Fig.1)  has  been  identified  as  the  major  bioactive 
component contributing to a variety of pharmacolog-
ical  effects  such  as  hepatitis  B  and  C  [21,22],  some 
cancers  [23],  and  cardiac  diseases  [24].  In  clinics, 
Matrine is currently used to treat cardiac arrhythmias, 
especially  premature  ventricular  beats  [25].  It  was 
reported  that  anti-arrhythmic  effect  of  Matrine  was 
due to the prolongation of APD and the inhibition of 
K+ currents in ventricular cardiomyocytes [26]. In ad-
dition,  Matrine  enhances  [Ca2+]i by  stimulating  ICa-L 
and  exerts  positive  inotropic  effects  on  electrically 
driven in guinea pig papillary muscles [27]. However, 
there is no published data regarding to the effects of 
Matrine on APD and ionic currents from atrial car-
diomyocytes. Therefore, the present study is designed 
to elucidate the effects of Matrine on AF and under-
lying  ion  channel  mechanisms  in  atrial  cardiomyo-
cytes. 
 
 
Fig.  1: Chemical structure of Matrine. (C15H24N2O, mo-
lecular weight = 248.36). 
 
Materials and methods 
Animals  
Mice (18 – 22 g, SPF, the Animal Center of Har-
bin Medical University) were housed at 20 ± 3 ºC with 
55 ± 10 % humidity, 12 h light/dark cycle, and had 
free access to species-specific food and tap water. All 
experiments were carried out according to the China 
Guide to the Care and Use of Experimental Animals. 
Experimental  protocols  used  in  the  present  study 
were pre-approved by the Institute Committee of the 
Animal Care of Harbin Medical University.  
Chemicals 
Matrine was obtained from Xian Botany Garden 
(Shanxi, China), and its purity was > 99% as assessed 
by  high-performance  liquid  chromatography  [28]. 
Matrine stock solution was prepared in double pol-
ished  distilled  water  (ddH2O).  4-(2-hydroxyehtyl) 
piperazine-1-ethanesulfonic  acid  (HEPES),  taurine, 
Na2-ATP, K asparate, collagenase (type II) were pur-
chased from Sigma (St Louis, MO, U.S.A.). 
Induction of atrial fibrillation in wild-type mice 
[29,30] 
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groups: control group, Matrine 15 mg/kg (low dose, 
Ma-L), 30 mg/kg (medium dose, Ma-M), 45 mg/kg 
(high dose, Ma-H) pretreatment group. Matrine were 
administrated  intravenously  (iv)  once  daily  for  15 
days  before  experiment.  Intracardiac  pacing  was 
performed  in  these  animals  by  inserting  an 
eight-electrode catheter (1.1 F, octapolar EP catheter, 
Science)  through  the  jugular  vein  and  advancing  it 
into the right atrium and ventricle. Atrial arrhythmias 
were introduced by applying 6-second bursts through 
the catheter electrodes using the automated stimula-
tor that was part of the data acquisition system. The 
cycle length (CL) in the first 6-second burst is 40 ms 
and decreases in each successive burst  with a 2-ms 
decrement down to a CL of 20 ms. Then 50 µg/kg 
carbachol  was  injected  through  the  jugular  vein  in 
model mice and the same combination of bursts was 
applied  again  at  two  minutes  after  carbachol.  Suc-
cessful AF was defined as a period of rapid irregular 
atrial rhythm lasting at least 1 second.  
Electrophysiological recording 
Single atrial cardiomyocytes were isolated from 
mouse heart by enzymatic dissociation according to 
the procedure previously described [31]. AP and ionic 
currents were studied in whole-cell patch configura-
tion at room temperature (21 ~ 23 ºC). Only quiescent 
rod-shaped cells lacking membrane deformities and 
showing clear cross striations were studied. A small 
aliquot  of  the  solution  containing  the  isolated  cells 
was placed in a 1.0 ml recording chamber mounted on 
the  stage  of  a  Nikon  Diaphot  inverted  microscope 
(Nikon,  Tokyo,  Japan).  Borosilicate  glass  electrodes 
with tip resistance of 2 ~ 5 MΩ were filled with the 
appropriate internal solution (in mM: 20 KCl, 110 po-
tassium asparate, 1.0 MgCl2, 5.0 HEPES, 10 EGTA, 5.0 
Na2-ATP,  with  pH  adjusted  to  7.2  with  KOH).  For 
Ca2+ current recordings, the recording electrodes were 
filled with appropriate internal solution (in mM: 20 
CsCl, 110 Cesium asparate, 1.0 MgCl2, 5.0 HEPES, 10 
EGTA, and 5.0 Na2-ATP with pH adjusted to 7.2 with 
CsOH).  Junction  potentials  were  zeroed  before  for-
mation of the membrane–pipette seal in Tyrode’s so-
lution.  Both  AP  and  membrane  currents  were  rec-
orded  with  an  Axo-patch  200B  amplifier  (Axon  In-
struments,  U.S.A).  After  forming  the  whole-cell  re-
cording configuration, a capacitive current transient 
induced by a 10 mV step from a holding voltage of 0 
mV was recorded and used for the calculation of cell 
capacitance. Series resistance (Rs) ranged from 4 ± 6 
MΩ was compensated by 60 to 80%. For measurement 
of K+ currents, the bath Tyrode’s solution was con-
tained in mM: 126 NaCl, 5.4 KCl, 1 MgCl2, 1.8 CaCl2, 
0.33  NaH2PO4,  10  glucose  and  10  HEPES  with  pH 
adjusted to 7.35 with NaOH. For Ca2+ measurement, 
the bath Tyrode’s solution was contained in mM 136 
Tris-HCl,  5.4  CsCl,  1.0  MgCl2,  1.8  CaCl2,  0.33 
NaH2PO4, 10 glucose and 10 HEPES with pH adjusted 
to 7.35 with Tris-OH. The estimated voltage error at-
tributed to uncompensated Rs (Rs x ICa-L) was below 5 
mV in all performed cells in the current experiments.  
Current-clamp was used to record AP of atrial 
cardiomyocytes triggered by a two milliseconds de-
polarizing stimulatory pulse. Voltage-clamp was used 
to record ionic currents. The recording protocols for 
both Ca2+ and K+ channel currents were described in 
the result section, respectively. 
Quantitative real-time RT-PCR analysis  
The SYBR Green PCR Master Mix Kit (Ambion) 
was  used  in  quantification  of  mRNA  in  our  study. 
Total  RNA  was  isolated  with  the  TRIzol  method 
(Invitrogen)  from  mouse  hearts.  Quantitative  re-
al-time  PCR  was  performed  on  7500  fast  Real-time 
PCR  System  (Applied  Biosystems)  for  40  cycles  (15 
seconds at 95°C, 15 seconds at 60°C and 30 seconds at 
72°C)  and  then  performed  dissociation  analysis 
(melt-curve) on the reactions to identify the charac-
teristic peak associated with primer-dimers in order to 
separate from the single prominent peak representing 
the successful PCR amplification. We first determined 
the appropriate cycle threshold (Ct) using the auto-
matic baseline determination feature. Fold variations 
in  expression  of  an  mRNA  between  RNA  samples 
were calculated. Real time PCR primer sequences are 
sense:  5’  GCCCTTCTTGTGCTCTTCGT3’  and  anti-
sense:  5’  GTTGGTGATGCCGTGCTT  3’  for 
CACNA1C  (mouse);  sense:  5’  CATCATCGGCA 
ACATCCT 3’ and antisense: 5’ GAGGTCACAGGCT 
AAGTTC 3’ for M3 (mouse); GADPH was served as 
an internal standard. 
Western blot analysis 
Mouse atrial tissue samples were directly frozen 
in liquid nitrogen following excision and further re-
duced to powder with a mortar. Powdered tissue was 
then  resuspended  in  a  cold  (4  ºC)  extraction  buffer 
containing in mM: 10 Tris (pH 7.4), 250 sucrose and 
Complete  EDTA-free  Protease  Inhibitor  Cocktail 
(Roche, Applied Science, USA) to avoid protein deg-
radation. The sample mixture was homogenized me-
chanically, incubated for 20 min on ice, and then cen-
trifuged at 100×g for 10 min to remove debris and 
nuclei.  The  supernatant  was  then  collected  and  the 
pellet was homogenized again. The latter procedure 
was repeated for three times to increase the efficiency 
of  protein  extraction.  Collected  supernatant  was  fi-
nally  centrifuged  at  100,000×g  using  an  Optima Int. J. Biol. Sci. 2012, 8 
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LE-80K  ultracentrifuge  (Beckman,  Instruments,  CA, 
USA).  The  pellet  corresponding  to  the  membrane 
fraction was resuspended in 1% Triton-X100 cold ex-
traction buffer and stored at -80 ºC. Membrane pro-
teins (~50 µg) were fractionated by SDS polyacryla-
mide gel electrophoresis (7.5% polyacrylamide gels) 
and  transferred  to  polyvinyl  difluoride  (PVDF) 
membranes. After transfer, membranes were blotted 
overnight  with  anti-M3  (1:1000)  antibodies  (Santa 
Cruz Biotechnology, , CA, USA) and goat polyclonal 
anti-  CACNA1C  (Santa  Cruz  Biotechnology,  CA, 
USA),  respectively.  The  next  day,  membranes  were 
incubated for 2 h with the secondary antibody (goat 
anti-rabbit IgG, 1:10000. Bands were visualized with 
enhanced chemiluminescence. GAPDH was used as 
an internal control for equal input of protein samples, 
using  anti-GAPDH  antibody.  Western  blot  bands 
were  quantified  using  Quantity  One  software  by 
measuring the band intensity (Area x OD) for each 
group and normalizing to GAPDH. The final results 
are expressed as fold changes by normalizing the data 
to the control values. 
Data analysis and statistics 
Clampfit 7.0 (Axon) and Original 7.0 were used 
for data analysis. Group data are expressed as mean ± 
S.D.  Two-way  analysis  of  variance  (ANOVA)  and 
Bonferroni-adjusted t-tests (in the case of significant 
inter-group  differences  by  ANOVA)  were  used  for 
statistical  comparisons  of  current-voltage  relations. 
Non-paired  t-tests  were  applied  for  inter-group 
comparisons of AF duration and western blot analy-
sis. P value less than 0.05 was considered to be sig-
nificant. 
Results  
Intracardiac electrophysiology 
In control group, AF incidence induced by elec-
tric pacing was 50 ± 20% and AF duration was 3.68 ± 
0.84 s; after application of carbachol 50 µg/kg, both 
AF incidence and AF duration were significantly in-
creased (P < 0.05) up to 86 ± 21% and 65.2 ± 20.1 s, 
respectively. Compared with control group, applica-
tion of Matrine decreased AF incidence and shortened 
AF duration in a dose-dependent manner. The similar 
results of Matrine were also confirmed in the presence 
of carbachol 50 µg/kg. Matrine 30 mg/kg decreased 
AF incidence to 34 ± 16% and shortened AF duration 
to  2.14  ±  1.06  s;  after  application  of  carbachol  50 
µg/kg, AF incidence was 56 ± 18% and AF duration 
was 56.7 ± 13.3 s (n = 6, P < 0.05) (Fig. 2).  
 
 
Fig. 2: Effects of Matrine on AF duration and incidence. (A) Representative intracardiac recordings. (B) and (C) Effects of 
pretreatment of Matrine 30 mg/kg on AF duration and AF incidence after electrical pacing. *P < 0.05 and 
#P < 0.05 versus 
control.Int. J. Biol. Sci. 2012, 8 
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Fig. 3: Effects of Matrine on APD of atrial myocytes. (A) Representative action potential traces recorded from single atrial 
cardiomyocytes of each group. (B) Comparisons of APD50 and APD90 of each group. *P < 0.05 and 
#P < 0.05 versus control. 
 
Effects of Matrine on Action Potential Dura-
tion 
To evaluate the effects of Matrine on the electric 
activity of atrial cardiomyocytes, the AP was recorded 
from  isolated  atrial  cardiomyocytes;  APD  and  ERP 
represented  as  the  ratio  of  APD50/APD90  (Rati-
oAPD50/90)  were  also  quantified.  In  control  group, 
APD50 and APD90 were 25.7 ± 2.81 ms and 72.9 ± 8.16 
ms.  Treatment  of  Matrine  prolonged  APD  in  a 
dose-dependent  manner.  In  the  case  of  Matrine  45 
mg/kg, both APD50 and APD90 were significantly in-
creased to 51.4 ± 5.89 ms and 95.5 ± 9.01 ms (n = 8, P < 
0.05)  (Fig.  3),  respectively.  Importantly,  the  Rati-
oAPD50/90 was absolutely increased from 0.35 ± 0.07 up 
to 0.54 ± 0.06 (P < 0.05, n = 8) as shown in Table 1. 
 
 
Table 1. Comparison of action potential duration (APD) in 
each group.  
    Control    Ma-L    Ma-M    Ma-H 
APD50 (ms)    25.2±2.81    28.6±4.44    32.6±3.98*    51.4±5.89# 
APD90(ms)    72.9±8.16    74.2±9.61
   
  80,3±9.19*    95.5±9.01* 
APD50/APD90    0.35±0.07    0.38±0.03    0.39±0.03*    0.54±0.06# 
APD50 50% repolarization of action potential duration; APD90 90% 
repolarization of action potential duration (n = 8, P* < 0.05; P#<0.01) 
 
 
Atrial tachypacing effects on IKM3 
IKM3 was elicited by depolarizing voltage steps in 
the presence of 10 mM choline and 0.1 mM CdCl to 
block ICa-L in the bath solution and the step-current 
amplitude was measured at the end of 2 s step. Rep-
resentative IKM3 recordings were illustrated in Fig. 4A. 
Matrine  blocked  the  currents  in  a  dose-dependent 
manner. At the test potential of +50 mV, the ampli-
tude of IKM3 was 3.57 ± 0.55 pA/pF in control group 
and this IKM3 was significantly reduced to 2.62 ± 0.48 
pA/pF and 1.44 ± 0.37 pA/pF (n = 8, P < 0.05) in the 
groups  pretreated  with  Matrine  30  mg/kg  and  45 
mg/kg, respectively.  
To  determine  whether  the  alterations  of  IKM3 
density in atrial cardiomyocytes can be explained by 
alterations  of  the  corresponding  M3-R  mRNA  and 
protein  expression  levels.  For  the  quantification  of 
M3-R  in  both  mRNA  and  protein  levels,  Real-time 
PCR  and  Western  blot  were  performed  with  mem-
brane samples extracted from atria, respectively. As 
shown in Fig. 4C and 4D, Matrine down-regulated the 
expression  level  of  M3-R  mRNA  and  protein 
dose-dependently.  
Effects of Matrine on L-type calcium currents 
Based upon the effect of  Matrine on APD, the 
changes in Ca2+ current mediated by Matrine would 
be expected. In the present experiment, the effect of 
Matrine on ICa-L was observed,  current-voltage rela-
tionship  (I-V  curve)  and  voltage-dependent  activa-
tion/inactivation profiles of ICa-L were analyzed. The 
results  showed  that  ICa-L  was  increased  by  Matrine 
does-dependently (Fig. 5A and 5B) without changing 
the peak voltage (+10 mV). At the test potential of +10 
mV, the current density was lower in cells from con-
trol  group  (-4.43  ±  1.02  pA/pF),  compared  with 
Matrine 30 mg/kg pretreatment group (-8.21 ± 1.22 
pA/pF, n = 8, P < 0.05). In addition, Matrine had no 
effect on the voltage-dependent activation and inac-
tivation profiles (Fig. 5C). 
To further confirm the electrophysiological ob-
servation  of  Matrine  on  ICa-L,  western  blot  analysis 
(Fig. 5D and 5E) and Real-time PCR were also per-Int. J. Biol. Sci. 2012, 8 
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formed. And the results indicated that Matrine only 
increased  functional  expression  of  the  membrane 
protein  α1C/Cav1.2,  which  is  consistent  with  the 
change in current density of ICa-L. While as Matrine 
had  not  significant  increase  in  mRNA  level  of 
α1C/Cav1.2. 
 
Fig. 4: Effects Matrine on M3-R expression and density of IKM3 in atrium. (A) Normalized traces of IKM3 elicited by 300 ms 
voltage step at test potential of +50 mV were derived from each group. (B) Current voltage (I-V) plots were shown for IKM3 
of each group. (C) Representative image for M3-R expression of atrium from each group. Data were normalized to GAPDH. 
(D) The mRNA level of M3-R was analysed by real-time PCR. *P < 0.05 and 
#P < 0.01 versus control. 
 
 
 
 
 
 
 
Fig. 5: Effects Matrine on α1C/Cav1.2 expres-
sion and density of ICa-L in atrium. (A) Normalized 
traces of ICa-L elicited by 300 ms voltage step at 
+10 mV were derived from each group. (B) and 
(C)  Current  voltage  (I-V)  plots  and  volt-
age-dependent activation and inactivation pro-
files  were  shown  for  ICa-L of  each  group.  (D) 
Representative  image  for  α1C/Cav1.2  expres-
sion and GAPDH from each group. Data were 
normalized to GAPDH. (E) The mRNA level of 
α1C/Cav1.2 was analysed by real-time PCR. *P < 
0.05 and 
#P < 0.01 versus control. 
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Discussion 
The  plausible  anti-AF  mechanisms  of  Matrine 
have  been  investigated  in  this  study,  which  clearly 
demonstrates, at the first time, that Matrine can mod-
ulate M3-R and L-type Ca2+ channel to exert anti-AF 
effect. And this notion is strongly supported by our 
following  evidence:  (1)  Matrine  could  decrease  AF 
incidence and shorten AF duration in vivo study; (2) 
Matrine  could  up-regulate  the  expression  of 
α1C/Cav1.2  and  ICa-L  and  down-regulate  the  M3-R 
expression  and  IKM3;  and  (3)  consequently  Matrine 
absolutely prolongs the APD and ERP as well by in-
creasing the ratio of ERP/APD. 
Animal models of AF were developed using long 
term rapid atrial pacing in large animals, such as dog 
and  goat  [17,  31,  32].  In  small  animals  such  as  the 
mouse, it has widely been accepted that the induction 
of fibrillatory tachycardia is impossible due to lack of 
a critical mass of the heart [33]. In our experiment, the 
intracellular  pacing  was  performed  by  the  first 
6-second burst with a cycle length (CL) of 40 ms, de-
creasing in each successive burst with a 2-ms decre-
ment down to a CL of 20 ms. Despite smaller mass of 
the normal mouse atria, it provides a micro-reentrant 
atrial  in  an  intact  normal  mouse  for  initiating  sus-
tained reentrant circuit (Fig. 2A), which allow us in-
vestigating  the  anti-AF  effects  and  possible  mecha-
nisms  of  Matrine  in  mouse  atrium.  The  cholinergic 
discharge increases the susceptibility  of AF through 
muscarinic receptor-mediated shortening of the atrial 
APD  and  ERP  [34-36].  So  Carbachol  50  µg/kg  has 
been selected to decrease refractoriness in atrial tissue 
and thereby shorten the wavelength of cardiac cycles, 
and expected results have been confirmed in current 
study, which demonstrates that Carbachol markedly 
increases and prolongs the incidence and duration of 
AF, conceivably allows for the maintenance of atrial 
tachycardia circuits. Intriguingly, in Matrine groups, 
incidence and duration of AF induced by intracellular 
electric pacing significantly decreased and shortened, 
especially in 30 mg/kg Matrine group. These results 
strongly suggest the anti-AF effect of Matrine. 
The  molecular  mechanisms  of  ion  channel  re-
modeling in AF, such as down-regulation of mRNA 
and protein functional expressions of Kv4.3, the α1c 
subunit of L-type Ca2+ channels, and the α-subunit of 
cardiac Na+ channels were observed through the dog 
chronic  AF  models  and  cultured  atrial  cardiomyo-
cytes  applied  by  electrical  pacing  [16,37,38].  So  far, 
there are no reports about the ion channel remodeling 
in intact mice with AF. In the present study, we used 
programmed pacing to initiate AF and sustain AF for 
certain time period by choosing the best cycle length 
of intracellular electric pacing in order to detect the 
membrane expression of M3-R, Cav1.2 channel, and 
other ionic currents. 
It  is  now  well  recognized  that  rapid  pacing 
causes  electrical  remodeling  in  the  atrium  that  ag-
gravates AF. With rapid pacing, the onset of remod-
eling is rapid with shortening of atrium repolarization 
in minutes or hours. Calcium overload via the ICa-L in 
AF is thought to play a key role in ion channel re-
modeling  and  apoptosis.  Under  this  circumstance, 
cardiomyocytes might trigger cytoprotective mecha-
nisms  by  down-regulation  of  mRNA  and  proteins 
encoded with L-type Ca2+ channels, and acceleration 
of its inactivation to reduce the Ca2+ influx. In clinical 
management  of  patients  with  AF,  calcium  channel 
blocker such as Verapamil is usually used to maintain 
sinus rhythm and decrease calcium overload.  How-
ever, it may promote AF by shortening the atrial APD 
and ERP. In our experiment, we found that Matrine 
not  only significantly shortened the duration  of AF 
but also dramatically increased the chances of spon-
taneous termination of AF. These electrophysiological 
data were consistent with our molecular evidence that 
Matrine up-regulated α1c subunit protein expression 
without effect on mRNA level and increased the cur-
rent density of ICa-L contributing to the prolongation of 
APD and ERP. In addition, Matrine could also pro-
long  APD  by  inhibiting  K+  channels  [28],  conse-
quently  prolonged  a  repolarization  and  further  in-
creased  the  ERP  of  the  myocardium.  Even  though 
Matrine  increases  Ca2+  influx  by  activating  Ca2+ 
channel,  it  does  not  induce  Ca2+  overload  through 
other cardiac protective mechanisms, such as inhib-
ited an apoptosis of myocardium and inhibited cal-
cium overload induced by Ang II [39]. 
Both  M2  and  M3  muscarinic  receptor-mediated 
K+ currents may be involved in the development of 
AF. In heart, M2-R-regulated IKACh comprises >60% of 
the  total  muscarinic  mediated  outward  K+  current. 
However,  with  AF  due  to  ventricular  tachypac-
ing-induced congestive heart failure, the density of M2 
receptors was significantly down-regulated with the 
reduction  of  IKACh  current  density  in  atrial  cells.  In 
sharp  contrast,  M3-R  expression  and  IKM3  current 
density was remarkably increased [12]. Intriguingly, 
our data demonstrated that the M3-R expression and 
IKM3 current densities were both reduced by the pre-
treatment with Matrine compared with normal atrial 
cardiomyocytes,  resulting  in  the  prolongation  of 
APD/ERP and termination of re-entry. Pathological 
conditions may be another factor influencing the ex-
pression and relative contribution of the cardiac M3-R, 
in other words, a minor role of the M3-R under phys-
iological conditions might become prominent under Int. J. Biol. Sci. 2012, 8 
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pathological situations [12]. So M3-R may be a new 
target for treatment of AF.  
Electrical  remodeling  due  to  rapid  atrial  rates 
has a central role in pathogenesis of AF. Decrease in 
IL-Ca, increase in inward rectifier K+ current (IK1), and 
active  M3-R  activated  K+  current  (IKM3)  are  all  con-
tribute  to  AF  by  APD  shortening  and  functional 
re-entry. Traditional anti-AF drugs simply inhibit K+ 
currents  (class  III)  or  Ca2+  currents  (class  Ⅳ).  More 
importantly, Class III drugs suppress re-entry by in-
creasing refractory periods, but can produce torsade 
de  pointes  arrhythmias  that  are  related  to  early  af-
ter-depolarizations.  Class  IV agents  are  frequently 
used  to  reduce  Ca2+  overload,  but  it  aggravates 
down-regulation of ICa-L in the atrium and promotes 
the risk of ventricular arrhythmia without the thera-
peutic  effect  on  AF.  However,  these  data  demon-
strated that Matrine possessed anti-AF effects through 
multiple targets, such as, the inhibition of M3-R me-
diated IKM3 and up-regulation of ICa-L.  
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